The Falsified Medicines Directive and the Commission Delegated Regulation set the procedure in accordance with which the safety features are to be verified and unique identifiers are to be decommissioned by wholesalers and persons who are allowed and entitled to deliver medicines to the public. In accordance with the Regulation and the currently enforced regulatory enactments in Latvia, among the persons who are allowed and entitled to deliver medicinal products to public in Latvia there are pharmacies, hospitals, clinics, polyclinics and health centres.

The Latvian Medicines Verification System shall include application programming interfaces allowing wholesalers, pharmacies, hospitals, clinics, polyclinics and health centres to query the repositories system by means of software for the purposes of verifying the authenticity of the unique identifiers and of decommissioning them in the repositories system (Article 32(4) of the Regulation).

In accordance with the Regulation, it shall be a duty of pharmacies and other persons allowed to supply medicinal products to the public in Latvia to establish an IT connection and access the national repositories system as well as to verify the unique identifiers of the packaging of medicinal products and decommission them in the repositories system by means of appropriate technical equipment (scanning equipment).

Each company’s IT system may be developed by the company’s internal IT employees or the company’s outsourcing partners. To comply with the requirements of the Regulation and the Directive, each company shall make an individual decision either to integrate the medicinal product verification and unique identifier decommissioning function in its existing IT solutions or to use these functions as a separate IT solution. This shall be an internal decision of each individual company.